HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits.

AbstractBACKGROUND:
Carbon monoxide-releasing molecules (CORMs) are a novel group of substances that are capable of modulating physiological functions via the liberation of CO.
AIMS:
This study was undertaken to investigate the effects of CORM-3, a water-soluble CO-releasing agent, on two rabbit models of ocular hypertension.
METHODS:
Ocular hypertension was induced by injecting alpha-chymotrypsin in the rabbit eye. The dose-response effect of CORM-3 on IOP was assessed by topical administration of the drug (0.001, 0.01, 0.1 and 1%). Ocular hypertension was also obtained by weekly subconjunctival injection of betamethasone, and animals were treated topically with CORM-3. A group of animals in both models was treated with the inactive form of the drug (iCORM-3).
RESULTS:
CORM-3 induced a dose-dependent reduction in IOP in rabbits treated with alpha-chymotrypsin. A similar reduction in IOP was observed in rabbits with betamethasone-induced ocular hypertension treated with the drug. Treatment with the iCORM-3 had no effect on IOP in both models.
CONCLUSIONS:
Treatment with CORM-3 is associated with a reduction in IOP in two different rabbit models of ocular hypertension. These results support previous findings on the effect of haem oxygenase-derived CO on IOP and suggest a direct involvement of CO system in the regulation of ocular pressure probably through the modulation of aqueous humour dynamics.
AuthorsE Stagni, M G Privitera, C Bucolo, G M Leggio, R Motterlini, F Drago
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 93 Issue 2 Pg. 254-7 (Feb 2009) ISSN: 1468-2079 [Electronic] England
PMID18977789 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Organometallic Compounds
  • tricarbonylchloro(glycinato)ruthenium(II)
  • alpha-chymotrypsin
  • Chymotrypsin
Topics
  • Animals
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Chymotrypsin
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical (methods)
  • Intraocular Pressure (drug effects)
  • Male
  • Ocular Hypertension (chemically induced, drug therapy, physiopathology)
  • Organometallic Compounds (administration & dosage, therapeutic use)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: